Pharmacokinetics of Indapamide by Oral in Human Body
LI Zuoji
Abstract
LI Zuoji
Abstract
OBJECTIVE:To establish a method for the determination of serum indapamide concentration.METHOD:10healthy male volunteers were assigned to receive7.5mg indapamide capsule on empty stomach with time-concentration deˉtermined by HPLC,and the pharmacokinetics parameters were accounted.RESULTS:C max was(0.212±0.167)mg/L,t max was(2.14±0.59)h,t 1/2 was(19.69±0.75)h,AUC 0~72 was(3.636±0.503)(mg·L)/h and AUC 0~∝ was(3.937±0.518)(mg·L)/h.CONCLUSION:The established method can be used for the clinical analysis on the use of indapamide and its pharmacokinetics study.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To establish a method for the determination of serum indapamide concentration.METHOD:10healthy male volunteers were assigned to receive7.5mg indapamide capsule on empty stomach with time-concentration deˉtermined by HPLC,and the pharmacokinetics parameters were accounted.RESULTS:C max was(0.212±0.167)mg/L,t max was(2.14±0.59)h,t 1/2 was(19.69±0.75)h,AUC 0~72 was(3.636±0.503)(mg·L)/h and AUC 0~∝ was(3.937±0.518)(mg·L)/h.CONCLUSION:The established method can be used for the clinical analysis on the use of indapamide and its pharmacokinetics study.
Key concepts: Indapamide, Pharmacokinetics, Capsule, Chromatography, Pharmacology, Chemistry, Medicine, Diuretic